Robert B. Hance, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 7,301 shares at $54.62 ($392K) on 2010-02-16, disclosed to the SEC on 2010-02-18.
Scheduled sale ($392k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 50 | $0 | 0.0% |
| 2 | $53.93 | 5,551 | $299K | 76.3% |
| 3 | $54.62 | 500 | $27K | 7.0% |
| 4 | $54.62 | 1,200 | $66K | 16.7% |
| Total | $53.72 avg | 7,301 | $392K | 100% |
| Filing → |
| ABT | SELL | 2012-03-02 | $4.6M | — | Filing → |
| ABT | SELL | 2011-12-16 | $4.2M | — | Filing → |
| ABT | SELL | 2011-03-02 | $75K | — | Filing → |